The purpose of this randomized, double-blind, placebo-controlled study will be to evaluate whether the daily intake of Keranat™ for 24 weeks can promote the gloss and elasticity of hairs, improve their density and strength, and reduce hair loss.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
100
KSRC Korean Skin Research Center
Seongnam-si, Gyeonggido, South Korea
The change of hair elasticity
To evaluate the change in hair elasticity between the Keranat™ and placebo group. Hair elasticity was measured using an Expert 7601Tension Testing System.
Time frame: Change of the week 24 from baseline
The change of hair gloss
To evaluate the change in hair gloss between the Keranat™ and placebo group. Hair gloss was measured using a Skin-Glossy meter GL200.
Time frame: Change of the week 24 from baseline
The change of hair thickness
To evaluate the change in hair thickness improvement between the Keranat™ and placebo group. Hair thinness was assessed by measuring hair diameter using a microscope and ToupLite software.
Time frame: Change of the week 24 from baseline
The change of anagen hair ratio(%)
To evaluate the change in the ratio of anagen hair between the Keranat™ and placebo group. Changes in Hair growth that occurred in the hair removal area for 3 days were analyzed using the Image-Pro® 10 program.
Time frame: Change of the week 24 from baseline
The change in hair loss amount
To evaluate the change in the number of hair loss between the Keranat™ and placebo group. Collected and counted the number of lost hair.
Time frame: Change of the week 24 from baseline
The change of number of hair per unit area
To evaluate the change in the number of hairs per unit area between the Keranat™ and placebo group. The number of hairs per unit area of the hair removal area was counted using Folliscope PS.
Time frame: Change of the week 24 from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The change of hair distribution score through clinical photography
To evaluate the change in hair distribution score through clinical photography between the Keranat™ and placebo group before and after intake. This evaluates improvement and deterioration on a 7-point scale, with higher scores meaning improvement. By comparing photos before and after intake, if there is no change, 0 points, improvement is a maximum of 3 points, and worsening is a minimum of -3 points.
Time frame: Change of the week 24 from baseline
Self-reported Hair health assessments
To evaluate the change in Hair health improvement between the Keranat™ and placebo group. The evaluation was conducted through Patient Report Outcome(PRO) using a standardized survey form. Survey allowing for participant-report changes in hair health as a result of intervention using a 7-point scale.
Time frame: Change of the week 24 from baseline
The change of serum levels of cytokines (IL-1, TNF-α, PGE2)
To evaluate the change in serum levels of cytokines through clinical photography between the Keranat™ and placebo group.
Time frame: Change of the week 24 from baseline